2012
DOI: 10.1182/blood.v120.21.2054.2054
|View full text |Cite
|
Sign up to set email alerts
|

Early Discharge and Out Patient Management After AML Induction Chemotherapy: Determinants of Safety

Abstract: 2054 Background: No clear consensus exists for the setting of supportive care after induction chemotherapy given for newly diagnosed acute myeloid leukemia (AML). While many centers provide care exclusively via in-patient settings, others including the Penn State Hershey Cancer Institute select suitable patients for discharge following chemotherapy and provide supportive care in out-patient infusion centers. Our single center practice offers 7 day a week tran… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles